Dr. Anthony R. Galan, MD

Dr. Galan practices at Texas Digestive Specialists in Harlingen, Texas.

Dr. Galan's NPI, 1609800663, was assigned on July 10, 2006. Dr. Galan graduated from Universidad Nacional Pedro Henriquez Urena in 1989. Dr. Galan holds Texas license K9064.

Dr. Galan's primary practice is Texas Digestive Specialists, at 512 Victoria Ln Ste 2 Suite 2, Harlingen, TX 78550. The practice phone is (956) 365-4400.

Dr. Galan's primary practice is Texas Digestive Specialists in Harlingen, Texas. Dr. Galan is also affiliated with Valley Baptist Medical Center - Harlingen. The medical group on file is Texas Digestive Specialists. Dmand AI also links Dr. Galan to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galan practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Galan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Galan's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists acid reflux, cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, peptic ulcer and upper GI endoscopy among the conditions Dr. Galan treats.

CMS data shows 453 Medicare services from Dr. Galan across 13 procedure codes in 2024, for 328 Medicare patients. Medicare paid $40,061 for them.

CMS counts 328 Medicare patients who saw Dr. Galan in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Galan's median patient age at 61, with 59% women.

In 2024, Dr. Galan wrote 593 Medicare Part D claims for 312 patients. 87% of them were for generic drugs. CMS names the drug for 493 of them, across 11 drugs with 11 or more claims each, at $24,126 in total drug cost. In 2023, CMS named 157 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 61 out of 100 for Dr. Galan for performance year 2024, reported as part of a group. Dr. Galan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 245 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Galan, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Galan. Dr. Galan's most frequent co-author is David A. Katzka, MD.

CMS Open Payments shows 26 general payments to Dr. Galan from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $117.

Dr. Galan graduated from Universidad Nacional Pedro Henriquez Urena in 1989.

Dr. Galan is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.